SEAL ROCK THERAPEUTICS
Seal Rock Therapeutics is a developer of small-molecule inhibitors of ASK1 (Apoptosis signal-regulating kinase 1), a protein that mediates apoptosis, inflammation, and fibrosis. Seal Rock is currently focusing its efforts on hepatic indications including NASH (non-alcoholic steatohepatitis), a condition resulting from fatty liver disease, characterized by hepatic inflammation and cellular damage that lead to liver fibrosis. Additional opportunities with ASK1 inhibitors include cardiac, immunological, and neurodegenerative indications.
SEAL ROCK THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2016-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.sealrocktx.com
Total Employee:
1+
Status:
Active
Contact:
786.453.0593
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Current Employees Featured
Founder
Investors List
Life Science Angels
Life Science Angels investment in Seed Round - Seal Rock Therapeutics
Life Science Angels
Life Science Angels investment in Seed Round - Seal Rock Therapeutics
Official Site Inspections
http://www.sealrocktx.com
- Host name: performance-center.az
- IP address: 192.185.16.193
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092